Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: 0.33 + web  Related to the article below (Last Update: 8/4/2008)

Web.com Reports Second Quarter 2008 Financial Results
istockAnalyst.com, OR -
"Despite challenging economic conditions, Web.com was able to hit the top of its quarterly revenue and earnings guidance. The operating leverage potential ...
Puget Energy Reports Second Quarter 2008 Financial Results
WELT ONLINE, Germany -
Second Quarter 2007 EPS Reconciliation Cents per diluted share Puget Energy?s second quarter 2007 earnings from PSE $ 0.33 Increase in natural gas margin ...PSD
Prophecy drills 45.5 metres of 0.33% copper and 0.003% Molybdenum ...
Canada NewsWire (press release), Canada - Jul 28, 2008
For further information: about Prophecy, please visit our web site at www.prophecyresource.com or contact us toll-free at (888) 818-8748.CVE:PCY - TSE:X - CVE:ETF

FLEXNEWS
Plum Creek Timber Company, Inc. Reports Results for Second Quarter ...
MarketWatch - Jul 28, 2008
A live webcast of the conference call may be accessed through Plum Creek's Web site at www.plumcreek.com by clicking on the "Investors" link. ...
Stratasys Reports Record Second Quarter Financial Results Trading Markets (press release)
EFI Reports Q2 2008 Results MarketWatch
all 1,227 news articles »  SSYS - PCL - EFII

WELT ONLINE
Aladdin Knowledge Systems Reports Second Quarter 2008 Financial ...
MarketWatch - Jul 21, 2008
Released Aladdin eSafe v6.2 Proxy, offering organizations more options in control and flexibility for secure Web gateway deployment. ...
Leadis Technology Reports Second Quarter 2008 Results MarketWatch
all 773 news articles »  LDIS - ALDN

CPI Financial
Peapack-Gladstone Financial Corporation Reports 27% Increase in ...
MarketWatch - Aug 1, 2008
To learn more about Peapack-Gladstone Financial Corporation and its services please visit our web site at www.pgbank.com or call 908-234-0700. ...
Bank of Hawaii Corporation Second Quarter 2008 Financial Results Trading Markets (press release)
Greene County Bancorp, Inc. Announces Earnings Increase MarketWatch
all 1,033 news articles »  GCBC - BOH - PGC
Waddell & Reed Financial, Inc. Reports Second Quarter Results
MarketWatch - Jul 29, 2008
Live access to the teleconference will be available on the "Corporate" section of our Web site at http://www.waddell.com. A Web cast replay will be made ...WDR
American Equity Reports Second Quarter 2008 Operating Income of ...
WELT ONLINE, Germany - Jul 30, 2008
An audio replay will be available shortly after the call on AEL?s web site. An audio replay will also be available via telephone through August 21, ...AEL
Digital River Announces Second Quarter Financial Results
MarketWatch - Jul 30, 2008
A webcast replay of the call will be archived on Digital River's corporate Web site. Digital River, Inc., a leading provider of global e-commerce solutions, ...DRIV
Kaboose Reports Record Second Quarter 2008 Results with Revenue ...
Canada NewsWire (press release), Canada - Jul 31, 2008
The webcast will be archived on the same web page for 30 days following the live call. The second quarter financial statements and related management's ...TSE:KAB - BOM:532354 - GIS
Source: Google News

Measuring the Independence of Central Banks and Its Effect on Policy Outcomes -
A Cukierman, SB Web, B Neyapti - The World Bank Economic Review, 1992 - World Bank
... 0.50 Unconditional dismissal possible by legislature 0.33 At executive's discretion
0.17 ... 0.67 Bank only advises government 0.33 Bank has no say 0.00 ...

Creating Adaptive Web Sites Through Usage-Based Clustering of URLs -
B Mobasher, R Cooley, J Srivastava - Proceedings of the 1999 Workshop on Knowledge and Data …, 1999 - doi.ieeecs.org
... In this paper we have presented an architecture for automatic Web personalization
based on Web usage data. ... research/mmdbms 0.34 /research/agassiz 0.33 ...

SILK MEDIATED DEFENSE BY AN ORB WEB SPIDER AGAINST PREDATORY MUD-DAUBER WASPS -
TA Blackledge, JW Wenzel - Behaviour, 2001 - Springer
... Sceliphron Enclosure 1 2 nd web 0.33 (12) 1.00 (2) Enclosure 2 2 nd web 0.00 (8) **
Chalybion 2 nd web 0.18 (28) 0.30 (33) 3 rd web 0.00 (14) 0.33 (15) ...

Web development: estimating quick-to-market software -
DJ Reifer, RC Inc - Software, IEEE, 2000 - ieeexplore.ieee.org
... Business-to-business applications 2.0 1.5 1.00 * Web-based information utilities
2.1 2.0 1.00 * * Either 0.5 or 0.33 depending on the scaling (>40 Web Objects) ...

[PDF] Mapping networks of terrorist cells -
VE Krebs - Connections, 2002 - insna.org
... 52 http://www.sfu.ca/insna/Connections-Web/Volume24-3/Valdis.Krebs.web.pdf ? 2002 ...
1.00 1.00 0.00 0.33 0.00 1.00 0.33 0.33 0.00 1.00 0.67 0.33 0.00 0.27 0.33 ...

The calculation of web impact factors -
P Ingwersen - Journal of Documentation, 1998 - ingentaconnect.com
... 4. Academic (.edu) 0.807 0.47 0.33 ?0.57 ?2.2 5,390,097 ... If the figures from the mainly
US web sectors are calculated together and taken as the current ...

[PDF] … importance and trophic role of heterotrophic dinoflagellates in a coastal pelagial food web -
PJ Hansen - Mar. Ecol. Prog. Ser, 1991 - int-res.com
... food web ... 0.33 to 1 O/O). The cells in at least 50 m1 were allowed to sediment and
the flagellates iden- tified and counted with an inverted microscope. ...

Variation in d 15 N and d 13 C trophic fractionation: implications for aquatic food web studies -
MJ Vander Zanden, JB Rasmussen - Limnology and Oceanography, 2001 - JSTOR
... 0.045 ' Nbaseline +0.55%0? +0.16 Minagawa and Wada (1984): +0.49%o +0.33 Pooled
sources ... web to be comprised of five trophic links, which is a con- servative ...

[PDF] Human Performance on Clustering Web Pages -
SA Macskassy, A Banerjee, BD Davison, H Hirsh - Proceedings of ACM SIGKDD International Conference on …, 1998 - athos.rutgers.edu
... Overall .12 .58 0.33 0.32 .13 .59 0.36 0.35 ... work began as an off-shoot of our
observation that it was difficult to build a system that clustered web pages when ...

… new entry to web page table upon receiving web page including link to another web page not having … -
LM Monier - US Patent 5,974,455, 1999 - freepatentsonline.com
... Network latency thus also tends to limit the number Web pages that can be processed
by prior art Web crawlers to about 0.33 Web pages per second. ...

Source: Google Scholar
 
 

TB4 Is Essential For Blood Vessel Regeneration In Adult Hearts

Article Date: 23 Nov 2006 - 12:00pm (PST)
REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN) (http://www.regenerx.com/) report that a study published in the advanced online edition of the journal Nature supported and elaborated TB4's significant effects in the damaged hearts of mice and highlighted its therapeutic potential for the treatment of heart attacks and heart failure in humans.

"TB4 is presented here as a single factor that can potentially couple myocardial [heart] and coronary vascular regeneration in failing mouse hearts," according to researchers from the University College London's Institute of Child Health, London, UK; Baylor College of Medicine, Houston, TX; Massachusetts General Cardiovascular Research Center, Boston, MA; and Harvard Medical School and Harvard Stem Cell Institute, Cambridge, MA.

"A major shortcoming of current angiogenic therapy in response to myocardial ischemia in humans is that the outcome may be limited to capillary growth without concomitant collateral support of arterioles [terminal branches of arteries]. Our findings that, in mice, TB4 can promote vessel formation and collateral growth not only during development but also critically from adult epicardium, suggest TB4 has considerable therapeutic potential in humans," stated the researchers.

Article continues below and (thank you)

 
"These results are very exciting because most humans suffering from ischemic cardiac events, either acutely or chronically, do not develop the collateral vessel growth necessary to preserve and restore heart tissue. If, in humans, we see the same effects as seen in mice, TB4 would be the first drug to prevent loss of [heart] muscle cells and restore blood flow in this manner and provide a new and much needed treatment modality for these patients," commented Deepak Srivastava, M.D., Professor and Director, Gladstone Institute of Cardiovascular Disease, University of California San Francisco, CA. Dr. Srivastava and his colleagues published the first paper on TB4's effects on myocardial infarction in Nature in November 2004.

The study was funded by the British Heart Foundation and the Medical Research Council.

Over 105,000 people die from heart disease in the UK each year. Heart attacks occur in over one million people annually in the United States and over thirteen million suffer from coronary artery disease, making it the single largest cause of death in the Western world.
 
The RegeneRx Technology Platform

Thymosin beta 4 (TB4) is a synthetic version of a naturally occurring peptide present in virtually all human cells. It is a first-in-class drug candidate that promotes endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, collagen deposition, and down-regulates inflammation. One of TB4's key mechanisms of action is its ability to regulate the cell-building protein, actin, a vital component of cell structure and movement. Of the thousands of proteins in cells, actin represents up to 10% of the total protein and, thus, plays a major role in the physiology of the cell. RegeneRx has identified several molecular variations of TB4 that may affect the aging of skin, among other properties, and could be important candidates as active ingredients in pharmaceutical and consumer products.

Researchers at the National Institutes of Health, and at other academic institutions throughout the U.S., have published numerous scientific articles indicating that TB4 is effective in accelerating dermal and corneal wound healing in several animal models, under a variety of conditions. In two articles published in the scientific journal, Nature, researchers found that TB4 protects heart tissue following a myocardial infarction (heart attack) and can regenerate coronary vessels in laboratory animals. Abstracts of scientific papers related to TB4's mechanisms of action may be viewed at RegeneRx's web page: http://www.regenerx.com/.

About RegeneRx Biopharmaceuticals, Inc.

RegeneRx is focused on the discovery and development of novel molecules to accelerate tissue and organ repair. Currently, RegeneRx is developing TB4, a 43 amino acid peptide, in part, under an exclusive world-wide license from the National Institutes of Health. Preliminary research suggests that TB4 may prove efficacious for multiple indications; therefore, RegeneRx is developing TB4 as a therapeutic platform. RegeneRx holds nearly 60 world-wide patents and patent applications related to dermal, ocular, and internal wounds and tissue repair, cardiac and neurological injuries, and septic shock. RegeneRx is currently sponsoring three Phase II chronic dermal wound healing clinical trials and has additionally targeted ophthalmic and cardiac trials in 2007 as part of its ongoing clinical development program.

Contact: Melanie Nimrodi
Financial Relations Board
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; Nedws9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 

 © 2002-2006

Keywords::

Contact Iconocast

Home Page